Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-02

Clinical Trial Update: A Safety and Efficacy of Homeopathic Medicine Rhus Toxicodendron 30 in the Treatment of Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing the safety and efficacy of Rhus Toxicodendron 30 for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rhus Toxicodendron 30

Snippet

Sponsor: Healthcare Homoeo Charitable Society | Conditions: Rheumatoid Arthritis. | Phase 2 | Status: UNKNOWN